BackBlackRock Health Sciences Term Trust Overview
BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust Discounted Cash Flow

Compare BlackRock Health Sciences Term Trust's DCF valuation ($3.1) to today's market price.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$3.07

Current Fair Value

$3.07
↓ 81.0% Downside

Overvalued by 81.0% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading

BlackRock Health Sciences Term Trust (BMEZ) FAQ

The latest DCF fair value for BMEZ is $3.1. Investors often review this figure alongside BlackRock Health Sciences Term Trust's historical trend and sector peers before judging valuation or financial health.

A DCF fair value of $3.1 for BlackRock Health Sciences Term Trust suggests the stock may be overvalued by roughly 81.0% at today's price. That does not mean the market is 'wrong'; it means the model's cash-flow assumptions imply a different intrinsic value. Stress-test the estimate by comparing it with historical valuation ranges and peer multiples.

After noting BMEZ's DCF fair value ($3.1), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.